InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: senderos post# 9340

Monday, 03/03/2014 11:41:25 AM

Monday, March 03, 2014 11:41:25 AM

Post# of 48316
$ONCS is completing the Phase2A trials for their three cancer treatments. We are awaiting results for the Melanoma now. $ONCS Merkel Cell and Cutaneous programs are completing their patient enrollment to fill their quota, however there are results for those enrolled earlier and we are awaiting more of these results which have been simply super so far. This should all become clearer over the next 2 to 3 months.


Meanwhile $ONCS CMO Dr. Pierce is planning a new 12 person Melanoma 4 th trial combining Electroporation + IL-12 + Anti PD-1 as a followup to $ONCS Melanoma Electroporation + IL-12 trial in which there was a 61.1% response rate, the highest among all the Pharmas.

$ONCS has many catalysts to drive up the PPS. My advice is to buy as much $ONCS that you can ASAP. I have.